09/15/2025 | Short News
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, celebrates nurses for the vital role they play in improving the quality of life of patients every day.
During Nephrology Nurses Week (September 14-20, ## Article Body 09/15/2025 | Short News Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, celebrates nurses for the vital role they play in improving the quality of life of patients every day. During Nephrology Nurses Week (September 14-20, 2025), FME reaffirms the commitment to professional growth and patient-centered care to ensure long-term resilience and quality patient care, which play a key role in the “FME Reignite” corporate strategy. “Our patients are at the heart of everything we do, and our nurses are beside them every step of the way, fostering strong relationships that impact every aspect of the patient's experience,” said Michelle Carver, Chief Nursing Officer and Senior Vice President, Nursing & Clinical Services. “As we celebrate nephrology nurses, we also recognize the vital need to care for the caregiver and continue supporting the well-being of our nurses.” Fresenius Medical Care offers comprehensive support, education, learning and development of nurses, including offering best practices, innovation, and practical advice for caregivers who support people with chronic kidney disease. To honor nurses, the company continues to prioritize their growth, professional development, and career advancement. As part of Nephrology Nurses Week, FME is also honoring care teams with The CARE (Caring About Renal Excellence) Award. The CARE Award is awarded annually to exceptional care team members who deliver unwavering commitment to providing exceptional care. Nephrology nurses receive The CARE Award during Nephrology Nurses Week, observed every year in mid-September. At The CARE Award annual recognition event, FME celebrates committed nephrology care team members who embody clinical excellence and have exemplified mastery in one of the following clinical pillars: quality and safety, growth, clinical leadership, clinical excellence, and patient experience. The CARE Award brings together hundreds of care team members from across the U.S., each nominated by their peers, leaders, and patients. Back To top: ## Recent Company News - 2026-07-29 07:00 EST — [Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients](https://biopharmsignal.com/news/FMS/fresenius-medical-care-announces-beacon-us-generating-real-world-evidence-suppor-8547f5f8) — Source: Fresenius Medical Care Ventures - 2026-07-20 07:00 EST — [Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy](https://biopharmsignal.com/news/FMS/fresenius-medical-care-introduces-therapywise-analytics-for-kidney-replacement-t-6fa82f2a) — Source: Fresenius Medical Care Ventures - 2026-06-10 07:00 EST — [Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model](https://biopharmsignal.com/news/FMS/interwell-health-delivers-strong-quality-scores-and-shared-savings-in-cms-value--e2c55e86) — Source: Fresenius Medical Care Ventures - 2026-06-03 07:00 EST — [Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-kinexus-worldwide-a-unified-digital-platform-to-support-home-dialysis) — Source: Fresenius Medical Care Ventures - 2026-05-28 07:00 EST — [Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-first-tranche-of-its-share-buyback-program-of-up-to-eur-600-million) — Source: Fresenius Medical Care Ventures ## Related News - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) - 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) - 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec) - 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)